Add to Twitter
Boehringer Ingelheim Invests More Than €200 Million to Establish Strategic Production Center for Veterinary Public Health in France
• With this new site, the company will be able to respond to the growing global demand for foot-and-mouth disease and Bluetongue virus control

• It represents a record investment into the company’s production network for Animal Health

• Boehringer Ingelheim will create approximately 100 new skilled jobs at the new site